MATTHEW HAROLD KATZ to Erlotinib Hydrochloride
This is a "connection" page, showing publications MATTHEW HAROLD KATZ has written about Erlotinib Hydrochloride.
Connection Strength
0.174
-
Angiogenin/Ribonuclease 5 Is an EGFR Ligand and a Serum Biomarker for Erlotinib Sensitivity in Pancreatic Cancer. Cancer Cell. 2018 04 09; 33(4):752-769.e8.
Score: 0.143
-
Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer. PLoS One. 2016; 11(6):e0156910.
Score: 0.032